Product information

Revlimid 7.5 mg
21
lenalidomide
3290863
0 / 10
Locked

Product properties

191732-72-6
L04AX04
Bristol-Myers Squibb Pharma
Capsule, hard
€1,430.96
EU/1/07/391/006
07640133681481
M44
Public
427551-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Commercial reasons) and no stock is available from wholesalers. Switching to an alternative is necessary.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Commercial reasons

Alternative available
Available
Until 31/05/2026

Composition

4 ingredients

Substance Type Strength CAS
Active ingredient
7.5 mg
191732-72-6
Excipient
144.5 mg
Excipient
Excipient

Additional information

View on BCPI

Availability statistics

Commercialization stopped
93 days
3
0
01/06/2026